These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12106979)

  • 21. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets.
    Siepmann J; Podual K; Sriwongjanya M; Peppas NA; Bodmeier R
    J Pharm Sci; 1999 Jan; 88(1):65-72. PubMed ID: 9874704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release.
    Fulzele SV; Satturwar PM; Dorle AK
    J Pharm Sci; 2007 Jan; 96(1):132-44. PubMed ID: 16960824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and Evaluation of Oral Dissolving Films of Amlodipine Besylate Using Blends of Starches With Hydroxypropyl Methyl Cellulose.
    Ayorinde JO; Odeniyi MA; Balogun-Agbaje O
    Polim Med; 2016; 46(1):45-51. PubMed ID: 28397418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted amylose matrices for oral drug delivery.
    Moghadam SH; Wang HW; Saddar El-Leithy E; Chebli C; Cartilier L
    Biomed Mater; 2007 Mar; 2(1):S71-7. PubMed ID: 18458424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
    Tadros MI
    Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
    Ravi PR; Ganga S; Saha RN
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements.
    Kiil S; Dam-Johansen K
    J Control Release; 2003 Jun; 90(1):1-21. PubMed ID: 12767703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices--influence of agitation rate and dissolution medium composition.
    Kavanagh N; Corrigan OI
    Int J Pharm; 2004 Jul; 279(1-2):141-52. PubMed ID: 15234802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations.
    Calinescu C; Mulhbacher J; Nadeau E; Fairbrother JM; Mateescu MA
    Eur J Pharm Biopharm; 2005 May; 60(1):53-60. PubMed ID: 15848056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.